Servier Bio-innovation Llc

This study is testing a new oral drug called S095035, both by itself and combined with another drug, for adults with advanced or metastatic solid tumors that have a specific genetic change (homozygous MTAP deletion). The main goals are to find a safe dose and see if the treatment…

This study is testing whether a daily pill called ivosidenib can slow the growth of an advanced form of bone cancer called chondrosarcoma in adults. It is for people whose cancer has a specific genetic change (IDH1 mutation) and has progressed after zero or one prior treatment. P…

This early study aims to understand the safety and how the body processes the cancer drug ivosidenib in people with specific genetic mutations who also have liver or kidney problems. It will enroll about 30 adults with various cancers who have these organ impairments, comparing t…